Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Duloxetine’s Dual Names: Lilly Wants Yentreve As Incontinence Brand

Oct 27 2003

• By The Pink Sheet

Related Content

Lilly Cymbalta Approval Timeline In Doubt After Delay In Second NDA

Sep 08 2003

FDA Drug Name Policy "Discourages" New Brand Names For Old Ingredients

Apr 23 2001

Rx Labeling Should Be Left To Manufacturers, Not FDA, Pfizer Says

Oct 07 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window